Tag: St Thomas Medical Partners

Poster-Disease-modifying Therapy

Real World Experience with Systemic Injection Reactions to Ofatumumab

Background: Ofatumumab is a subcutaneously administered B cell depleting agent approved by the FDA for use in patients with relapsing forms...

Read More

Platform-Psychosocial

Cogeval in the Real World: Feasibility, Implementation, and Practical Implications

Background: Cognitive dysfunction in multiple sclerosis (MS) patients is common, and routine/efficient screening for cognitive dysfunction...

Read More